Ledger.Open graph →
SEC Form D · Amendment · filed March 26, 2024

Avenzo Therapeutics, Inc

Offering
$346.9M
Sold
$223.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Athena Countouriotis · San Diego, CAExec · DirectorCarl Gordon · San Diego, CADirectorJudith Li · San Diego, CADirectorScott Lipman · San Diego, CAExecMohammad Hirmand · San Diego, CAExecBrian Sun · San Diego, CAExecPaolo Tombesi · San Diego, CAExecSimeon George · San Diego, CADirectorMichael Rome · New York, NYDirectorMichael Rome · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗